Loading organizations...
Loading organizations...
Clinical-stage biopharmaceutical developing migraine treatment.
Satsuma Pharmaceuticals has raised $74.0M across 2 funding rounds.
Satsuma Pharmaceuticals has raised $74.0M in total across 2 funding rounds.
Satsuma Pharmaceuticals has raised $74.0M in total across 2 funding rounds.
Satsuma Pharmaceuticals's investors include Wellington Management, CAM Capital, Cormorant Asset Management, Eventide Asset Management, Lumira Ventures, Osage University Partners, RA Capital Management, SBI Investment, SNBL, Surveyor Capital, TPG Biotech, Rajeev Shah.
Satsuma Pharmaceuticals has raised $74.0M across 2 funding rounds. Most recently, it raised $62.0M Series B in April 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 25, 2019 | $62.0M Series B | Wellington Management | CAM Capital, Cormorant Asset Management, Eventide Asset Management, Lumira Ventures, Osage University Partners, RA Capital Management, SBI Investment, SNBL, Surveyor Capital, TPG Biotech |
| Jan 6, 2017 | $12.0M Series A | Rajeev Shah, Heath Lukatch |